Heath Lukatch, Director at Vaxcyte, Inc. (PCVX), sold 5,000 shares at $71.50 ($358K) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Scheduled sale ($358k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCVX | SELL | 2023-01-12 | $15K | — | Filing → |
| PCVX | SELL | 2022-12-14 | $15K | — | Filing → |
| PCVX | SELL | 2022-11-15 | $200K | — | Filing → |